Physician profile
Marnie Baker
NPI 1013907377
$2,892.07
in general payments reported to CMS, 2019-2025
34 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $84.71 · 2022: $387 · 2023: $571 · 2024: $241 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $448.77 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $331.73 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Amgen INC. | $219.49 | 2022-2023 | Tezspire, Otezla, Enbrel |
| Glaxosmithkline, LLC. | $209.46 | 2019-2025 | Shingrix, Bexsero, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.58 | 2019-2024 | Cyltezo |
| Astrazeneca Pharmaceuticals LP | $201.26 | 2019-2023 | Evusheld |
| Exact Sciences Corporation | $140.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Neurocrine Biosciences, INC. | $139.48 | 2022-2025 | |
| Pfizer INC. | $108.42 | 2019 | |
| Sanofi Pasteur INC. | $95.02 | 2019-2025 | |
| Idorsia Pharmaceuticals US INC | $87.36 | 2023-2024 | Quviviq |
| Alk-Abello, INC | $73.16 | 2025 | Neffy |
| Fisher & Paykel Healthcare INC | $48.72 | 2022 | |
| Dexcom, INC. | $45.15 | 2023-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $43.99 | 2025 | Omnipod |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $43.96 | 2019 | |
| Biosense Webster, INC. | $41.15 | 2025 | Carto 3 |
| Averitas Pharma INC. | $32.20 | 2024 | Qutenza |
| Axsome Therapeutics, INC. | $28.48 | 2025 | Symbravo |
| Abbvie INC. | $28.39 | 2023 | Botox |
| Biogen, INC. | $27.96 | 2023 | Vumerity, Avonex |
| Mayne Pharma Commercial LLC | $26.83 | 2022 | |
| Bausch Health US, LLC | $26.45 | 2023 | Aplenzin |
| Lucid Diagnostics INC. | $24.46 | 2022 | |
| Dynavax Technologies Corporation | $24.21 | 2024 | Heplisav-B |
| Alexion Pharmaceuticals, INC. | $23.88 | 2020 | |
| Amarin Pharma, INC. | $23.71 | 2020 | |
| Kaleo, INC. | $21.93 | 2022 | |
| Medtronic USA, INC. | $21.61 | 2019 | |
| Livanova USA, INC. | $21.08 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $20.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.67 | 2023 | Xarelto |
| Abbott Laboratories | $19.34 | 2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $16.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marnie Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.